CN101612352A - A kind of medicine for the treatment of diabetes - Google Patents
A kind of medicine for the treatment of diabetes Download PDFInfo
- Publication number
- CN101612352A CN101612352A CN200810050102A CN200810050102A CN101612352A CN 101612352 A CN101612352 A CN 101612352A CN 200810050102 A CN200810050102 A CN 200810050102A CN 200810050102 A CN200810050102 A CN 200810050102A CN 101612352 A CN101612352 A CN 101612352A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- medicine
- diabetes
- treatment
- yugan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of medicine for the treatment of diabetes, make by weight ratio: Rhizoma Polygonati Odorati 10～15, Rhizoma Coptidis 12～18, Rhizoma Curcumae Longae 9～12, Yugan 8～15, Radix Rehmanniae 15～18, Fructus Lycii 10～15, the Rhizoma Atractylodis Macrocephalae 8～15, Rhizoma Dioscoreae 8～15 by following raw material.This medicine can soak back decoction or pulverization by its proportioning and incapsulate and carry out orally, and it is remarkable to have a therapeutic effect, and taking convenience, characteristics such as have no side effect.
Description
Technical field
The invention belongs to a kind of medicine for the treatment of diabetes.
Background technology
Diabetes are multiple difficult miscellaneous diseases of a kind of endocrine metabolism whole body chronic progressive external development, the tradition traditional Chinese medical science is referred to as to quench one's thirst, it is the cardiovascular and cerebrovascular disease that continues, the disease of the 3rd position influence human health after the cancer, polyuria is arranged, polydipsia, polyphagia, fatigue and weak, multiple symptom such as lose weight, and diabetes often cause that various complication comprise hypertension, heart disease, renal failure, apoplexy, pulmonary tuberculosis, skin pruritus, sexual dysfunction, visual deterioration, dizzy unable, diseases such as toothache, diabetotherapy one is an oral antidiabetic drug, the 2nd, insulin injection, oral medicine has certain side effect, and needing the normal phase to take, therapeutic effect is not fine.Though among the people have a Chinese herbal medicine secret recipe that much has hypoglycemic lipid-lowering effect, need prepare voluntarily mostly, take after decocting into water preparation, to use inconveniently, effect is also undesirable.
Summary of the invention
The objective of the invention is to overcome above prior art deficiency, provide a kind of treatment diabetes and complication effect thereof remarkable, the medicine of taking convenience, the treatment diabetes that have no side effect.
The objective of the invention is to be achieved through the following technical solutions:
A kind of medicine for the treatment of diabetes is made by weight ratio by following raw material: Rhizoma Polygonati Odorati 10～15, Rhizoma Coptidis 12～18, Rhizoma Curcumae Longae 9～12, Yugan 8～15, Radix Rehmanniae 15～18, Fructus Lycii 10～15, the Rhizoma Atractylodis Macrocephalae 8～15, Rhizoma Dioscoreae 8～15.
Optimum weight part of the present invention is: Rhizoma Polygonati Odorati 12.5, Rhizoma Coptidis 15.5, Rhizoma Curcumae Longae 10.5, Yugan 11.5, Radix Rehmanniae 16.5, Fructus Lycii 12.5, the Rhizoma Atractylodis Macrocephalae 11.5, Rhizoma Dioscoreae 11.5.
Clinical experiment: this medicine carries out clinical treatment to 100 many cases diabetes patients, and effective percentage reaches 90%.Wherein the state of an illness is than light or medical history shorter one, and subjective symptoms is improved, and a part of patient still can keep euglycemia level after the meal after progressively withdrawing antidiabetic drug.Heavier or the medical history of the state of an illness can comparatively ideally be kept blood sugar level than the elder with this medicine.Not only can stop the continuation of various complication to develop, worsen to this medicine of diabetic complication patient, and multiple pathological changes is had therapeutical effect preferably.
The specific embodiment
Embodiment 1: take by weighing raw material (g of unit) by following weight:
Rhizoma Polygonati Odorati 10, Rhizoma Coptidis 12, Rhizoma Curcumae Longae 9, Yugan 8, Radix Rehmanniae 15, Fructus Lycii 10, the Rhizoma Atractylodis Macrocephalae 8, Rhizoma Dioscoreae 8.
Embodiment 2: take by weighing raw material (g of unit) by following weight:
Rhizoma Polygonati Odorati 12.5, Rhizoma Coptidis 15.5, Rhizoma Curcumae Longae 10.5, Yugan 11.5, Radix Rehmanniae 16.5, Fructus Lycii 12.5, the Rhizoma Atractylodis Macrocephalae 11.5, Rhizoma Dioscoreae 11.5.
Embodiment 3: take by weighing raw material (g of unit) by following weight:
Rhizoma Polygonati Odorati 15, Rhizoma Coptidis 18, Rhizoma Curcumae Longae 12, Yugan 15, Radix Rehmanniae 18, Fructus Lycii 15, the Rhizoma Atractylodis Macrocephalae 15, Rhizoma Dioscoreae 15.
Instructions of taking is that above drug ratio mixes and soaks the back decoction, every day early, evening oral each once.Perhaps with pulverization after the said medicine proportioning, the capsule of packing into then No. 1 carries out orally, and each oral 4～6, every day 3 times, 30 days is a course of treatment.
Claims (2)
1, a kind of medicine for the treatment of diabetes is characterized in that: made by weight ratio by following raw material: Rhizoma Polygonati Odorati 10～15, Rhizoma Coptidis 12～18, Rhizoma Curcumae Longae 9～12, Yugan 8～15, Radix Rehmanniae 15～18, Fructus Lycii 10～15, the Rhizoma Atractylodis Macrocephalae 8～15, Rhizoma Dioscoreae 8～15.
2, the medicine of treatment diabetes according to claim 1 is characterized in that: Rhizoma Polygonati Odorati 12.5, Rhizoma Coptidis 15.5, Rhizoma Curcumae Longae 10.5, Yugan 11.5, Radix Rehmanniae 16.5, Fructus Lycii 12.5, the Rhizoma Atractylodis Macrocephalae 11.5, Rhizoma Dioscoreae 11.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810050102A CN101612352A (en) | 2008-06-23 | 2008-06-23 | A kind of medicine for the treatment of diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810050102A CN101612352A (en) | 2008-06-23 | 2008-06-23 | A kind of medicine for the treatment of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101612352A true CN101612352A (en) | 2009-12-30 |
Family
ID=41492361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200810050102A Pending CN101612352A (en) | 2008-06-23 | 2008-06-23 | A kind of medicine for the treatment of diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101612352A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103301213A (en) * | 2013-06-19 | 2013-09-18 | 张志忠 | Medicament for treating toothache caused by fire |
| CN104857456A (en) * | 2015-06-16 | 2015-08-26 | 王会玲 | Traditional Chinese medicine for treating diabetes mellitus and preparation method thereof |
| CN104997023A (en) * | 2015-06-23 | 2015-10-28 | 青岛浩大海洋保健食品有限公司 | Composite abalone and trepang liquid having efficacy of reducing blood sugar |
-
2008
- 2008-06-23 CN CN200810050102A patent/CN101612352A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103301213A (en) * | 2013-06-19 | 2013-09-18 | 张志忠 | Medicament for treating toothache caused by fire |
| CN103301213B (en) * | 2013-06-19 | 2014-12-17 | 张志忠 | Medicament for treating toothache caused by fire |
| CN104857456A (en) * | 2015-06-16 | 2015-08-26 | 王会玲 | Traditional Chinese medicine for treating diabetes mellitus and preparation method thereof |
| CN104997023A (en) * | 2015-06-23 | 2015-10-28 | 青岛浩大海洋保健食品有限公司 | Composite abalone and trepang liquid having efficacy of reducing blood sugar |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101507765B (en) | Medicine for treating cerebrovascular disease and sequela thereof and preparation method thereof | |
| CN102743540A (en) | Combined blood sugar-reduction formula | |
| CN101716242B (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
| CN101904994B (en) | Chinese medicinal preparation for treating diabetes mellitus | |
| CN101366926A (en) | Chinese medicinal composition for treating deficiency of both qi and yin type diabetes | |
| CN100493572C (en) | Composition of medication for treating diabetes | |
| CN101406598B (en) | Chinese medicine composite for treating diabetes and preparation method thereof | |
| CN102429977B (en) | Medicine for treating diabetes | |
| CN102698058B (en) | Health care extract for adjusting sub-healthy state of human body | |
| CN102579610B (en) | Chinese medicinal composition for treating cerebral hemorrhage and preparation method thereof | |
| CN101612352A (en) | A kind of medicine for the treatment of diabetes | |
| CN101607031B (en) | Medicated wine for curing and preventing diabetes mellitus, preparation method and application method thereof | |
| CN103007159B (en) | Chinese medicinal preparation for correcting pancreas islet function | |
| CN102886019A (en) | Traditional Chinese medicinal blood sugar reducing plaster | |
| CN1319555C (en) | Medicine for treating prostate hyperplasia and method of preparing the same | |
| CN102652821B (en) | Traditional Chinese medicine extract for treating yin deficiency and fire hyperactivity type phthisis and preparation method of traditional Chinese medicine extract | |
| CN105012864A (en) | New crystal form of mianserin hydrochloride, detection method and applications thereof | |
| CN104888124A (en) | Synthetic process and detection method for mianserin hydrochloride | |
| CN1305501C (en) | Diabetes treating medicine | |
| CN103263580A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN103263595A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN100348236C (en) | Medicine for treating diabetes | |
| CN101559134A (en) | Chinese materia medica preparation for treating rosacea | |
| CN103599278B (en) | Traditional Chinese medicine for treating diabetes | |
| CN102526614A (en) | Chinese medicinal kidney healing powder for treating chronic renal failure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20091230 |